Intracranial and fatal bleeding according to indication for long-term oral anticoagulant therapy
Author:
Publisher
Wiley
Subject
Hematology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1538-7836.2010.04016.x/fullpdf
Reference50 articles.
1. Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients;Schulman;J Thromb Haemost,2005
2. Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups;Gorter;Neurology,1999
3. Assessing the quality of reports of randomized clinical trials: is blinding necessary?;Jadad;Control Clin Trials,1996
4. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial;Connolly;Lancet,2006
5. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study;Petersen;Lancet,1989
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Major bleeding during oral anticoagulant therapy associated with factor V activation by factor Xa;Journal of Thrombosis and Haemostasis;2021-11-23
2. Quelle est la durée du traitement anticoagulant pour une EP/TVP proximale ?;Revue des Maladies Respiratoires;2021-04
3. Cost-effectiveness of rivaroxaban compared with enoxaparin plus warfarin for the treatment of hospitalised acute deep vein thrombosis in China;BMJ Open;2020-07
4. Shared Decision-Making for Anticoagulation in Atrial Fibrillation: Do Physicians Really Listen?;Canadian Journal of Cardiology;2020-04
5. Cost-effectiveness of rivaroxaban versus apixaban for the initial treatment of venous thromboembolism and extended prevention of recurrences in the UK;Journal of Medical Economics;2019-09-19
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3